These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22883697)

  • 1. International initiatives on extemporaneous dispensing.
    Nunn A; Aindow A; Woods D
    Int J Pharm; 2012 Oct; 435(2):135-7. PubMed ID: 22883697
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drugs for children--when temporary solutions become routine].
    Kalikstad B; Westergren T
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):930-2. PubMed ID: 16554887
    [No Abstract]   [Full Text] [Related]  

  • 3. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
    Conroy S
    Acta Paediatr; 2003 Apr; 92(4):408-10. PubMed ID: 12801103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of essential drugs. Third report of the WHO Expert Committee.
    World Health Organ Tech Rep Ser; 1988; 770():1-63. PubMed ID: 3140500
    [No Abstract]   [Full Text] [Related]  

  • 5. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
    Brion F; Nunn AJ; Rieutord A
    Acta Paediatr; 2003 Apr; 92(4):486-90. PubMed ID: 12801118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtieth report.
    World Health Organ Tech Rep Ser; 1987; 748():1-50. PubMed ID: 3111103
    [No Abstract]   [Full Text] [Related]  

  • 8. Poor preservation efficacy versus quality and safety of pediatric extemporaneous liquids.
    Ghulam A; Keen K; Tuleu C; Wong IC; Long PF
    Ann Pharmacother; 2007 May; 41(5):857-60. PubMed ID: 17440007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-third report.
    World Health Organ Tech Rep Ser; 1993; 834():1-30. PubMed ID: 8362524
    [No Abstract]   [Full Text] [Related]  

  • 10. Access to essential medicines for children: the world health organization's global response.
    Zucker H; Rägo L
    Clin Pharmacol Ther; 2007 Nov; 82(5):503-5. PubMed ID: 17952106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of drugs: principles and problems. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1973 Nov; 536():1-17. PubMed ID: 4204708
    [No Abstract]   [Full Text] [Related]  

  • 12. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making medicines that children can take.
    Nunn AJ
    Arch Dis Child; 2003 May; 88(5):369-71. PubMed ID: 12716697
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sample and titer of pharmaceutical forms].
    Setnikar I
    Boll Chim Farm; 1968 Mar; 107(3):168-72. PubMed ID: 5730324
    [No Abstract]   [Full Text] [Related]  

  • 15. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Twenty-fourth report.
    World Health Organ Tech Rep Ser; 1972; 487():1-86. PubMed ID: 4623961
    [No Abstract]   [Full Text] [Related]  

  • 16. Role and functions of the International Pharmacopoeia.
    Wieniawski W
    Ann Ist Super Sanita; 1975; 11(3-4):204-10. PubMed ID: 1234722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of essential drugs. Report of a WHO expert committee.
    World Health Organ Tech Rep Ser; 1983; 685():1-46. PubMed ID: 6408810
    [No Abstract]   [Full Text] [Related]  

  • 18. WHO criticised for ignoring drug dumping.
    Wise J
    BMJ; 1997 Sep; 315(7109):626. PubMed ID: 9310559
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug safety: the viewpoint of the pharmaceutical manufacturing industry.
    Wigle WW
    Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099
    [No Abstract]   [Full Text] [Related]  

  • 20. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1980; 645():1-54. PubMed ID: 6774485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.